Explore

Trendline Trendline
Decoy Therapeutics to Present Business Outlook at Virtual Investor Event

Decoy Therapeutics to Present Business Outlook at Virtual Investor Event

Decoy Therapeutics to Present Business Outlook at Virtual Investor Event
Trendline Trendline
Vyome to Present Phase 2 Clinical Data on VT-1953 for MFW Treatment at AACR 2026

Vyome to Present Phase 2 Clinical Data on VT-1953 for MFW Treatment at AACR 2026

Vyome to Present Phase 2 Clinical Data on VT-1953 for MFW Treatment at AACR 2026
Trendline Trendline
Anima Biotech Introduces BioGPU to Enhance AI-Driven Drug Discovery

Anima Biotech Introduces BioGPU to Enhance AI-Driven Drug Discovery

Anima Biotech Introduces BioGPU to Enhance AI-Driven Drug Discovery
Trendline Trendline
OneCyte and Kemp Proteins Partner to Enhance Biopharma Cell Line Development

OneCyte and Kemp Proteins Partner to Enhance Biopharma Cell Line Development

OneCyte and Kemp Proteins Partner to Enhance Biopharma Cell Line Development
Trendline Trendline
OneCyte and Kemp Proteins Partner to Enhance Cell Line Development with Machine Learning

OneCyte and Kemp Proteins Partner to Enhance Cell Line Development with Machine Learning

OneCyte and Kemp Proteins Partner to Enhance Cell Line Development with Machine Learning
Trendline Trendline
Augmented Intelligence Revolutionizes Biopharma Innovation Amid Investment Challenges

Augmented Intelligence Revolutionizes Biopharma Innovation Amid Investment Challenges

Augmented Intelligence Revolutionizes Biopharma Innovation Amid Investment Challenges
Trendline Trendline
API's Strategic Approach to Drug Development Aims to Overcome 'Valley of Death'

API's Strategic Approach to Drug Development Aims to Overcome 'Valley of Death'

API's Strategic Approach to Drug Development Aims to Overcome 'Valley of Death'
Trendline Trendline
Regeneron and TriNetX Collaborate to Enhance Genomic and Health Data Integration

Regeneron and TriNetX Collaborate to Enhance Genomic and Health Data Integration

Regeneron and TriNetX Collaborate to Enhance Genomic and Health Data Integration
Trendline Trendline
BioNTech to Close Singapore mRNA Manufacturing Site Amid Strategic Shift

BioNTech to Close Singapore mRNA Manufacturing Site Amid Strategic Shift

BioNTech to Close Singapore mRNA Manufacturing Site Amid Strategic Shift
Trendline Trendline
Aspect Biosystems Secures $280 Million Partnership with Canadian Government to Boost Bioengineered Medicines

Aspect Biosystems Secures $280 Million Partnership with Canadian Government to Boost Bioengineered Medicines

Aspect Biosystems Secures $280 Million Partnership with Canadian Government to Boost Bioengineered Medicines
Trendline Trendline
Becton, Dickinson and Company Transforms into High-Growth Medical Technology Leader

Becton, Dickinson and Company Transforms into High-Growth Medical Technology Leader

Becton, Dickinson and Company Transforms into High-Growth Medical Technology Leader
Trendline Trendline
BioNTech to Close Singapore mRNA Facility Amid Strategic Shift

BioNTech to Close Singapore mRNA Facility Amid Strategic Shift

BioNTech to Close Singapore mRNA Facility Amid Strategic Shift